A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

T. E. Witzig, K. M. Laumann, M. Q. Lacy, S. R. Hayman, A. Dispenzieri, S. Kumar, C. B. Reeder, V. Roy, J. A. Lust, M. A. Gertz, P. R. Greipp, H. Hassoun, S. J. Mandrekar, S. V. Rajkumar

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences